| Literature DB >> 29159090 |
Kate Millington1, Victoria Miller2, Ronald C Rubenstein3, Andrea Kelly4.
Abstract
BACKGROUND: Cystic Fibrosis Related Diabetes (CFRD) is an increasingly common complication in CF. CFRD introduces an additional complex chronic disease to individuals already attending to demanding treatment regimens. An improved understanding of the reaction to and coping mechanisms surrounding CFRD may facilitate management of CFRD.Entities:
Keywords: Adherence; Cystic fibrosis; Diabetes
Year: 2014 PMID: 29159090 PMCID: PMC5685035 DOI: 10.1016/j.jcte.2014.07.003
Source DB: PubMed Journal: J Clin Transl Endocrinol ISSN: 2214-6237
Illustrative quotes
| Prior knowledge of diabetes | “I'll never forget going to the meeting [CF Education Night] and talking about this CF related diabetes and we're like, ‘Oh no, what is that now?’ It was scary to hear about that just going through the years. I wasn't happy to hear about that. I thought we would never have to worry about it.” (P11) |
| Reactions to CFRD management | “At first I thought it was going to, like, be really really hard and I wouldn't know what to do at first, but then as time went by I got the feel for it and its becoming a part of my every day routine and just something I do every day now.” (C5) |
| Barriers to CFRD treatment adherence | “Before I go to bed I'm just super tired and I just want to go to bed and I don't want to check my sugar and I forget about it. In the morning I'm super busy, especially when I get up for school, and I have a lot of things to do and I’ll be running out the door and I’ll forget my sugar.” (C4) |
| Factors promoting CFRD treatment adherence | “I got an ulcer on my arm … and I was like, ‘I'm not going to have these all over my body, absolutely not.’ I'm very vain so I pride myself in my looks. I'm not going to walk around with ulcers on my body or lose my feet or my fingers. That's not going to happen to me because there's too much that I have planned for myself.” (A7) |
| Patient responsibility for CFRD management | “He decided that he was going to take [CFRD] on as one of his responsibilities. So that's … he does it … and I think he's more comfortable doing it. Sometimes I think he does it because he knows it bothers me to do it so he takes that on himself.” (P1) |
| Role of the health care team | “Anytime I need anything, you know, a call or a text or an email away. They really help me, they support me that way.” (A5) |
A = adult participant, C = child participant, P = parent participant.
Demographic and clinical characteristics of participants
| Child participants | Adult participants | Parent Participants | |
|---|---|---|---|
| Female, % ( | 30% (3) | 30% (3) | 80% (8) |
| White, % ( | 90% (9) | 90% (9) | 90% (9) |
| Age, years; mean (SD), | 14.6 (2.2) | 29.5 (9.6) | 47.6 (9.1) |
| 10–17 | 19–48 | 37–64 | |
| Age of child, years; mean (SD), | – | – | 14.6 (2.1) |
| 10–17 | |||
| Married; % ( | – | 30% (3) | 70% (7) |
| Household income; % ( | |||
| < $20,000 | – | 40% (4) | 10% (1) |
| $20,001–$60,000 | – | 10% (1) | 20% (2) |
| $60,001–$100,000 | – | 10% (1) | 40% (4) |
| >$100,000 | – | 30% (3) | 30% (3) |
| Age of patient | 12.5 (2.1) | 19.9 (8.5) | 12.7 (2.1) |
| 10–15 | 9–35 | 10–15 | |
| Duration of patient's CFRD diagnosis, years; mean (SD), | 2.2 (1.5) | 9.6 (4.3) | 2.0 (1.6) |
| 0–4 | 4–18 | 0–4 | |
| Patient BMI; mean (SD), | 20.4 (2.9) | 23.5 (1.7) | 20.1 (2.9) |
| 16.0–25.8 | 20.6–25.5 | 16.0–25.8 | |
| Patient HbA1c; mean (SD), | 5.7 (0.6) | 8.0 (1.7) | 5.7 (0.6) |
| 4.8–6.7 | 6.2–10.1 | 4.8–6.7 | |
| Patient FEV1 % of predicted value; mean (SD), | 83.4 (25.9) | 67.1 (27.4) | 83.4 (25.9) |
| 38–113 | 43–130 | 38–113 | |
| Patient FVC % of predicted value; mean (SD), | 93.2 (20.3) | 75.3 (24.5) | 93.2 (20.3) |
| 53–115 | 47–125 | 53–115 | |
| CFQ-R score | |||
| Scales | |||
| Physical | 75.7 (20.9) | 74.1 (28.9) | 76.2 (23) |
| Emotion | 70.1 (21.3) | 73.3 (12.9) | 69.2 (12.4) |
| Body image | 58.9 (30.6) | 78.9 (21.9) | 61.1 (21.5) |
| Eating | 73.3 (32.8) | 97.8 (4.7) | 70 (37.5) |
| Treatment burden | 54.4 (17.1) | 58.3 (22.1) | 41.7 (30.7) |
| Respiratory | 60.2 (27.3) | 72.9 (5.5) | 71 (17.2) |
| Digestive | 74.4 (30.1) | 86.7 (20.2) | 61.1 (17.2) |
One parent participant had a child (not included as a child participant) with severe autism.
For parent participants, “patient” data refer to their children with CFRD.
Parent participants reported on their children's quality of life.
Combined scores for CFQ-child (age < 14y, n = 3) and CFQ-teen/adult (age ≥ 14y, n = 7) were combined for the “child” participants.
Figure 1HbA1C and Quality of Life in CFRD. No relationships between HbA1C and various CFQ-R subscales were observed in children with CFRD (○), their parents (●), and adults with CFRD (×).
Factors impeding and facilitating CFRD treatment adherence
| Factors impeding CFRD treatment adherence | Factors promoting CFRD treatment adherence |
|---|---|
Competing priorities (9/10 children, 6/10 adults) | Incorporating CFRD into existing routines (5/10 children, 3/10 adults, 6/10 parents) |
Interference between CF and CFRD (3/10 children, 3/10 adults) | Fear of increased morbidity or mortality (2/10 children, 3/10 adults) |
Embarrassment completing treatments in public (1/10 children, 4/10 adults) | Experiencing an adverse event (1/10 adults) |
Avoidance Of pain (6/10 children, 3/10 adults) | Seeing positive effects from treatment (i.e. improved lung function) (1/10 children, 5/10 adults) |
Not seeing effects of treatment (1/10 children, 2/10 adults) | Avoiding disappointment of parents or providers (1/10 children, 1/10 adults) |
Minimizing importance of glucose testing (4/10 children, 4/10 adults) | Support or supervision of parents or other adults (5/10 children) |
Child resistance (3/10 parents) | Organization of medications and supplies (1/10 parents) |